FDA Clears CereMetrix®’s Neuroimaging Analytics and Clinical Workflow Platform
CereMetrix Silver will feature advanced neuroimaging capabilities that automatically pinpoints and quantifies brain function down to the voxel level. DENVER, COLORADO, March 13, 2018 – CereMetrix®, a subsidiary of CereHealth Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its neuroimaging analytics and quantification platform CereMetrix Silver. Providers will now have access to […]
